This overexpression of HER2 gives rise to HER2-positive breast cancer, which is characterized by the absence of hormone receptors (ER < 1% and PR < 20%) and the presence of high levels of HER2 (>10%) [59]. This evidence concerns the gene ERBB2 and breast carcinoma.